On May 21, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Johnson & Johnson for its single-dose vaccine against COVID-19.

The agreement was for a commitment to purchase 200 million doses on behalf of the COVAX Facility, with the goal of them being supplied to Facility participants in 2021.